Clinical Trial Data Analysis Using R and SAS (Record no. 4101)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02624 a2200385 4500 |
| 001 - CONTROL NUMBER | |
| control field | 1498779530 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250317111601.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 250312042017xx 100 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781498779531 |
| 037 ## - SOURCE OF ACQUISITION | |
| Source of stock number/acquisition | Taylor & Francis |
| Terms of availability | GBP 47.99 |
| Form of issue | BB |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | 01 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MBGR1 |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MBNS |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PS |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | TDCW |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PBT |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MBGR1 |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MBNS |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PS |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | TDCW |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PBT |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MAT029000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MED071000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MED090000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | 610.727 |
| Source | bisac |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ding-Geng (Din) Chen |
| 245 10 - TITLE STATEMENT | |
| Title | Clinical Trial Data Analysis Using R and SAS |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 2 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Chapman and Hall/CRC |
| Date of publication, distribution, etc. | 20170601 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 410 p |
| 520 ## - SUMMARY, ETC. | |
| Expansion of summary note | Review of the First Edition "The goal of this book, as stated by the authors, is to fill the knowledge gap that exists between developed statistical methods and the applications of these methods. Overall, this book achieves the goal successfully and does a nice job. I would highly recommend it …The example-based approach is easy to follow and makes the book a very helpful desktop reference for many biostatistics methods." — Journal of Statistical Software Clinical Trial Data Analysis Using R and SAS, Second Edition provides a thorough presentation of biostatistical analyses of clinical trial data with step-by-step implementations using R and SAS. The book’s practical, detailed approach draws on the authors’ 30 years’ experience in biostatistical research and clinical development. The authors develop step-by-step analysis code using appropriate R packages and functions and SAS PROCS, which enables readers to gain an understanding of the analysis methods and R and SAS implementation so that they can use these two popular software packages to analyze their own clinical trial data. What’s New in the Second Edition Adds SAS programs along with the R programs for clinical trial data analysis. Updates all the statistical analysis with updated R packages. Includes correlated data analysis with multivariate analysis of variance. Applies R and SAS to clinical trial data from hypertension, duodenal ulcer, beta blockers, familial andenomatous polyposis, and breast cancer trials. Covers the biostatistical aspects of various clinical trials, including treatment comparisons, time-to-event endpoints, longitudinal clinical trials, and bioequivalence trials. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Karl E. Peace |
| Relationship | A01 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pinggao Zhang |
| Relationship | A01 |
No items available.